Generally, greater patient compliance and reduced morbidity may be anticipated with the usage of the lengthier-acting benzodiazepines, considering the fact that withdrawal signs or symptoms are less extreme.While ketamine is a really weak ligand on the monoamine transporters (Ki > 60 ?M), it has been advised that it might interact with allosteric s